{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:01:19Z","timestamp":1794895279888,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002507","name":"Kangwon National University","doi-asserted-by":"publisher","award":["120141488"],"award-info":[{"award-number":["120141488"]}],"id":[{"id":"10.13039\/501100002507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03031499"],"award-info":[{"award-number":["2017R1D1A1B03031499"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jhep.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T02:31:02Z","timestamp":1533090662000},"page":"1066-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":255,"title":["Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"Ji Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Don","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek Gyu","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Tae","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gab Jin","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Koo","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.07.018_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.07.018_b0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0015","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.3748\/wjg.v19.i39.6515","article-title":"Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy","volume":"19","author":"Wong","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.07.018_b0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jhep.2015.05.019","article-title":"Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?","volume":"63","author":"Wong","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0025","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1136\/gutjnl-2013-306409","article-title":"Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease","volume":"63","author":"Cho","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.07.018_b0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.07.033","article-title":"Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis","volume":"68","author":"Sharma","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3350\/cmh.2016.0086","article-title":"Risk score model for the development of hepatocellular carcinoma in treatment-naive patients receiving oral antiviral treatment for chronic hepatitis B","volume":"23","author":"Sohn","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ajg.2016.480","article-title":"Development of risk prediction model for hepatocellular carcinoma progression of indeterminate nodules in hepatitis B Virus-related cirrhotic liver","volume":"112","author":"Cho","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.07.018_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.2007.13.2043","article-title":"High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma","volume":"26","author":"Chan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2018.07.018_b0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2013.09.029","article-title":"Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B","volume":"60","author":"Wong","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0060","doi-asserted-by":"crossref","first-page":"e1646","DOI":"10.1016\/j.cgh.2016.05.039","article-title":"Association between level of fibrosis, rather than antiviral regimen, and outcomes of patients with chronic hepatitis B","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.07.018_b0070","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s10620-008-0541-2","article-title":"Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B","volume":"54","author":"Kim","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.07.018_b0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Disease. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.07.018_b0080","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.7314\/APJCP.2012.13.12.6163","article-title":"A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea","volume":"13","author":"Seo","year":"2012","journal-title":"Asian Pacific J Cancer Prevent: APJCP"},{"key":"10.1016\/j.jhep.2018.07.018_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3350\/cmh.2012.18.2.109","article-title":"KASL Clinical Practice Guidelines: Management of chronic hepatitis B","volume":"18","author":"Korean Association for the Study of the Liver","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0090","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/JCM.01306-10","article-title":"Performance of version 2.0 of the Cobas AmpliPrep\/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification","volume":"48","author":"Chevaliez","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2018.07.018_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1423-0410.2001.00003.x","article-title":"An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques","volume":"80","author":"Saldanha","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.jhep.2018.07.018_b0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2018.07.018_b0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jhep.2018.07.018_b0110","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers","volume":"28","author":"Wong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2018.07.018_b0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2018.07.018_b0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/sim.1433","article-title":"Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials","volume":"22","author":"Sullivan","year":"2003","journal-title":"Stat Med"},{"key":"10.1016\/j.jhep.2018.07.018_b0130","doi-asserted-by":"crossref","first-page":"113213","DOI":"10.18632\/oncotarget.22375","article-title":"Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study","volume":"8","author":"Seo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2018.07.018_b0135","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/liv.13450","article-title":"Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir","volume":"37","author":"Kim","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.07.018_b0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cgh.2017.08.042","article-title":"Role of age and race in the risk of hepatocellular carcinoma in veterans with hepatitis B virus infection","volume":"16","author":"Mittal","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13450","article-title":"Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir","author":"Kim","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.07.018_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0033-1345716","article-title":"Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to","volume":"33","author":"Liu","year":"2013","journal-title":"J Semin Liver Dis"},{"key":"10.1016\/j.jhep.2018.07.018_b0155","first-page":"601","article-title":"Do we need to determine viral genotype in treating chronic hepatitis B?","volume":"17","author":"Cooksley","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2018.07.018_b0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","article-title":"Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B","volume":"118","author":"Kao","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.07.018_b0165","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study of The Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.07.018_b0170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2018.07.018_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29320","article-title":"The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B","author":"Papatheodoridis","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.07.018_b0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.07.018_b0185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818322748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818322748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:55:04Z","timestamp":1584021304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818322748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0168827818322748"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.07.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}